A previous study showed altered purinergic receptor-Ca2+ signaling in endothelial growth factor (EGF)-induced epithelial–mesenchymal transition (EMT) and later in hypoxia-induced EMT in breast cancer cells [18,19]. Here, P2RY2 is linked to breast cancer.